QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 164 filers reported holding QIAGEN NV in Q4 2013. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $66,000 | -1.5% | 2,359 | -3.1% | 0.00% | – |
| Q3 2016 | $67,000 | -21.2% | 2,434 | -36.7% | 0.00% | – |
| Q2 2016 | $85,000 | -50.9% | 3,846 | -50.1% | 0.00% | – |
| Q1 2016 | $173,000 | -16.0% | 7,712 | +3.8% | 0.00% | – |
| Q4 2015 | $206,000 | +37.3% | 7,429 | +27.5% | 0.00% | – |
| Q3 2015 | $150,000 | -2.0% | 5,825 | -5.0% | 0.00% | – |
| Q2 2015 | $153,000 | +47.1% | 6,134 | +48.8% | 0.00% | – |
| Q1 2015 | $104,000 | -83.5% | 4,122 | -84.6% | 0.00% | – |
| Q4 2014 | $630,000 | -38.8% | 26,840 | -40.6% | 0.00% | -100.0% |
| Q3 2014 | $1,029,000 | +263.6% | 45,196 | +290.6% | 0.00% | – |
| Q2 2014 | $283,000 | -16.8% | 11,571 | -28.2% | 0.00% | – |
| Q1 2014 | $340,000 | -14.8% | 16,111 | -4.0% | 0.00% | – |
| Q4 2013 | $399,000 | +280.0% | 16,784 | +242.3% | 0.00% | – |
| Q3 2013 | $105,000 | -54.1% | 4,904 | -57.5% | 0.00% | – |
| Q2 2013 | $229,000 | – | 11,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
| Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
| Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
| Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
| Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
| Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
| CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
| Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
| PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |